Triglycerides Glucose Index on Angiographic Profiling of Non-Diabetic Premature Coronary Artery Disease Patients

Recruiting now

Conditions studied: Triglycerides Glucose Index, Angiographic Profiling, Non-Diabetic, Premature, Coronary Artery Disease

In brief

This study aims to evaluate the impact of the triglyceride-glucose (TyG) index on the angiographic profiling of non-diabetic patients with premature coronary artery disease (CAD).

Key facts

Study ID

NCT07154186

Run by

Sohag University

People needed

180

Starts

2025-09-04

Expected to finish

2026-02-01

Last updated by the study team

2025-09-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥18 years old.
• Both sexes.
• Non-diabetic patients [no history of diabetes, hemoglobin A1C (HbA1C) < 6.5%, fasting glucose < 126 mg/dL].
• Confirmed diagnosis of coronary artery disease (CAD) by coronary angiography.

You may not qualify if…

• Known diabetes mellitus (type 1 or type 2).
• Previous history of coronary revascularization.
• Severe hepatic or renal dysfunction [alanine transaminase (ALT)/aspartate aminotransferase (AST) ≥ 5× upper limit of normal (ULN), estimated glomerular filtration rate (eGFR)< 30 mL/min/1.73 m²].
• Malignant disease, autoimmune disease, or systemic inflammatory disorders.
• Current use of triglyceride-lowering medications.

Where it is running

• Sohag University — Sohag, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.